Results 221 to 230 of about 342,150 (384)

O‐025: Identification of ISG20 as the Nuclease involved in Interferon‐induced Decline of HBV cccDNA [PDF]

, 2018

openalex   +1 more source

Post‐Exposure Hepatitis B‐Treatment in Newborns: A Qualitative Study on Interprofessional Practices in Norway

Acta Paediatrica, EarlyView.
ABSTRACT Aim Children born to mothers with chronic Hepatitis B virus (HBV) infection are at substantial risk of developing chronic HBV‐infection without appropriate perinatal post‐exposure treatment. This study aimed to explore midwives' and public health nurses' (PHNs) experiences with HBV‐post‐exposure treatment for infants and identify factors ...
Brita Askeland Winje, Kristine Follstad, Ida Ueland, Signe Zenia Hulgaard‐Bruvold, Margrethe Greve‐Isdahl   +4 more
wiley   +1 more source

Non‐Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary Cholangitis

Alimentary Pharmacology &Therapeutics, EarlyView.
In a multi‐centre study of obeticholic acid in primary biliary cholangitis, 45% discontinued the drug over 4 years, with 11% moving to combination therapy (fibrates). Of those continuing, response rates increased from 37% (1 year) to 55% (4 years). Non‐response at 12 months and cirrhosis were independent predictors of liver‐related events.
Nadir Abbas, Rachel Smith, Ellina Lytvyak, Miki Scaravaglio, Neil Halliday, Amal Almahroos, Nadia Eden, Diane Lloyd‐Madden, Sanchit Sharma, James Ferguson, Jessica K. Dyson, Douglas Thorburn, David Jones, Aldo J. Montano‐Loza, Marco Carbone, Pietro Invernizzi, George Mells, Emma L. Culver, Palak J. Trivedi   +18 more
wiley   +1 more source

When HBV-GN Mimics Lupus Nephritis: A Case of Adult-Onset Disease With Full House Pattern [PDF]

Kei Kono, Naoki Sawa, Hiroki Mizuno, Yuki Oba, Noriko Inoue, Akinari Sekine, Kiho Tanaka, Masayuki Yamanouchi, Eiko Hasegawa, Tatsuya Suwabe, Satoshi Saitoh, Takeshi Fujii, Yutaka Takazawa, Kenichi Ohashi, Takehiko Wada, Junichi Hohino   +15 more
openalex   +1 more source

HBV [PDF]

, 2011
openaire   +1 more source

Chronic blood-borne viral hepatitis in a tertiary hospital in Al-Baha, Saudi Arabia: epidemiology, liver enzyme correlations, and treatment outcomes. [PDF]

BMC Infect Dis
Sallam TA, El-Badry RM, Alkully TH, Alfahemi HH, Halwani MA, Alzahrani KI, Alghamdi MA.   +6 more
europepmc   +1 more source

Impact of Hepatitis B Virus (HBV) X Gene Mutations on Hepatocellular Carcinoma Development in Chronic HBV Infection [PDF]

, 2013
Jong-Han Lee, Kwang‐Hyub Han, Jae Myun Lee, Jeon Han Park, Hyun Sook Kim   +4 more
openalex   +1 more source

Alterations in Gut Microbiota and Metabolism in Cirrhotic Portal Hypertension: Implications for Disease Progression

Alimentary Pharmacology &Therapeutics, EarlyView.
In‐depth multiomics analyses revealed that the gut microbiota in patients with CPH is dysbiotic. Altered gut microbiota plays an important role in the progression of CPH and affects the host's arginine metabolism to promote arginine biosynthesis. The pro‐inflammatory effects of certain gut bacteria induce iNOS expression, which together act on the ...
Qun Zhang, Jinghua Cui, Yixin Hou, Lining Guo, Hai Li, Guiqin Zhou, Xiaojing Wang, Bingbing Zhu, Ke Shi, Yi Zhang, Yufei Bi, Yanqiu Li, Lina Sun, Ying Feng, Jing Yuan, Xianbo Wang   +15 more
wiley   +1 more source

Panduratin A from Boesenbergia rotunda suppresses hepatitis B virus by targeting HNF1α and synergizing with antiviral agents. [PDF]

Chin Med
Thongsri P, Pewkliang Y, Borwornpinyo S, Wongkajornsilp A, Ruenraroengsak P, Anurathapan U, Sobhonslidsuk A, Hongeng S, Sa-Ngiamsuntorn K.   +8 more
europepmc   +1 more source

A non-viral CRISPR/Cas9 delivery system for therapeutically targeting HBV DNA and pcsk9 in vivo

Cell Research, 2017
Chao Jiang, Miao Mei, Bin Li, Xiurui Zhu, Wenhong Zu, Yujie Tian, Qiannan Wang, Yong Guo, Yizhou Dong, Xu Tan   +9 more
semanticscholar   +1 more source